Literature DB >> 28287873

On inference of control-based imputation for analysis of repeated binary outcomes with missing data.

Fei Gao1, Guanghan Liu2, Donglin Zeng1, Guoqing Diao3, Joseph F Heyse2, Joseph G Ibrahim1,4.   

Abstract

Missing data are common in longitudinal clinical trials. How to handle missing data is critical for both sponsors and regulatory agencies to assess treatment effect from the trials. Recently, a control-based imputation has been proposed, where the missing data are imputed based on the assumption that patients who discontinued the test drug will have a similar response profile to the patients in the control group. Under control-based imputation, the variance estimation may be biased using Rubin's formula which could produce biased statistical inferences. We evaluate several statistical methods for obtaining appropriate variances under control-based imputation for analysis of repeated binary outcomes with monotone missing data and show that both the analytical method developed by Robins & Wang and the nonparametric bootstrap method provide more appropriate variance estimates under various simulation settings. We use the methods in an application of an antidepressant Phase III clinical trial and give discussion and recommendations on method performance and preference.

Entities:  

Keywords:  Bootstrap; control-based imputation; missing data; multiple imputation; repeated outcomes

Mesh:

Substances:

Year:  2017        PMID: 28287873     DOI: 10.1080/10543406.2017.1289957

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  2 in total

1.  Efficient Multiple Imputation for Sensitivity Analysis of Recurrent Events Data with Informative Censoring.

Authors:  Guoqing Diao; Guanghan F Liu; Donglin Zeng; Yilong Zhang; Gregory Golm; Joseph F Heyse; Joseph G Ibrahim
Journal:  Stat Biopharm Res       Date:  2020-11-05       Impact factor: 1.586

2.  Reference-based multiple imputation for missing data sensitivity analyses in trial-based cost-effectiveness analysis.

Authors:  Baptiste Leurent; Manuel Gomes; Suzie Cro; Nicola Wiles; James R Carpenter
Journal:  Health Econ       Date:  2019-12-17       Impact factor: 3.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.